Product Information
TRAVOPROST 0.004% EYE DROP is a generic product labeled by Apotex Corp., priced at $9.7475 per ML under NDC 60505059301. Its NADAC has been published 342 times since Mar 18, 2020.
FDA first approved this application on Jul 10, 2015. Its Orange Book therapeutic-equivalence code is AT2.
Strength
.04 mg/mL
Manufacturer
Apotex Corp.NDC
60505059301
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TRAVOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA203431FDA Approved
7/10/2015
TE Code
AT2
On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for TRAVOPROST 0.004% EYE DROP has been published 342 times since Mar 18, 2020, and over the history we have for it it has declined 80.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7475 per ML |
|---|---|
| All-time high | $50.2232 (Apr 15, 2020) |
| All-time low | $8.4375 (Jul 22, 2026) |
| 52-week high | $10.9937 |
| 52-week low | $8.4375 |
| Median price | $20.0688 |
| Average price | $24.7240 |
| Largest weekly change | +30.7% (Jun 19, 2024) |
| Weeks tracked | 342 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
travoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAVOPROST 0.004% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TRAVOPROST 0.004% EYE DROP, manufactured by Apotex Corp., is $9.7475 per ML (NDC 60505059301), effective Sep 30, 2026.
How has the price of TRAVOPROST 0.004% EYE DROP changed over time?
Over the history we have for it, the NADAC for TRAVOPROST 0.004% EYE DROP has declined 80.6%. It has been tracked across 342 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for TRAVOPROST 0.004% EYE DROP?
Since Mar 18, 2020, the NADAC for TRAVOPROST 0.004% EYE DROP has ranged from a low of $8.4375 (Jul 22, 2026) to a high of $50.2232 (Apr 15, 2020), with a median of $20.0688 per ML.
Are there cheaper alternatives to TRAVOPROST 0.004% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAVOPROST 0.004% EYE DROP, is $8.3941 per ML — about 14% below TRAVOPROST 0.004% EYE DROP.
Who manufactures TRAVOPROST 0.004% EYE DROP?
TRAVOPROST 0.004% EYE DROP (NDC 60505059301) is labeled by Apotex Corp., and CMS classifies it as a generic product.